Merck & Co.’s first-in-class HIF-2 alpha inhibitor Welireg is touching down in the clear cell renal cell carcinoma (ccRCC) | ...
IQVIA Digital has developed technology to help pharma marketers identify nurse practitioners (NPs) and physician associates ...
In patients with BTK-pretreated chronic lymphocytic leukemia (CLL), AbbVie and Roche’s Venclexta (venetoclax) is the drug to ...
Eisai snares government manufacturing grant as it brings Leqembi packaging to UK with $65M expansion
As the United Kingdom juggles industry concerns about the region’s waning appeal and competitiveness, Eisai is getting a lift from a production-tinged fund that the British government first unveiled ...
In a plenary session at the 2026 European Hematology Association (EHA) annual meeting in Stockholm, Johnson & Johnson brought ...
An independent research firm is reviewing data on Amgen’s Tavneos as the company prepares for a hearing with the FDA which ...
Gilead’s lenacapavir has been on the market since 2022, when it was approved in the U.S. as Sunlenca for twice-yearly ...
Twenty-six years of chasing New York City sex crimes as the face of “Law & Order: Special Victims Unit” has prepared ...
While patients in Novo trials don't need to take any action, the company recommends patients "remain vigilant and report to ...
Three short films created through an Eli Lilly-sponsored initiative are premiering at the Tribeca Festival, furthering the ...
Madrigal Pharmaceuticals has installed a 20-foot-tall, 41-foot-wide inflatable liver in a Philadelphia park to mark Global ...
Staring down a $6 billion patent cliff for its prostate cancer drug Xtandi, Astellas aims to counter the inevitable revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results